MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 8, Issue 1, Pages 13-21
Publisher
Springer Nature
Online
2011-12-06
DOI
10.1038/nrneurol.2011.190
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria
- (2011) Hans-Peter Hartung et al. LANCET NEUROLOGY
- The Holy Grail in diagnostic neuroradiology: 3T or 3D?
- (2010) Frederik Barkhof et al. EUROPEAN RADIOLOGY
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis
- (2010) Maria Pia Sormani et al. Multiple Sclerosis Journal
- Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs
- (2010) MP Sormani et al. Multiple Sclerosis Journal
- Assessing changes in relapse rates in multiple sclerosis
- (2010) Seidu Inusah et al. Multiple Sclerosis Journal
- Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach
- (2010) M. P. Sormani et al. NEUROLOGY
- Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?
- (2010) F. Barkhof et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Detection of Active Multiple Sclerosis Lesions: 3D Subtraction Imaging
- (2010) Bastiaan Moraal et al. RADIOLOGY
- Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach
- (2009) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- NSF prevention in clinical practice: Summary of recommendations and guidelines in the United States, Canada, and Europe
- (2009) Tim Leiner et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
- MRI—the perfect surrogate marker for multiple sclerosis?
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
- Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration
- (2009) Arno Klein et al. NEUROIMAGE
- High field MRI in the diagnosis of multiple sclerosis: high field–high yield?
- (2009) Mike P. Wattjes et al. NEURORADIOLOGY
- MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
- (2008) Frank G. Shellock et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
- (2008) Machteld M. Vellinga et al. BRAIN
- Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis
- (2008) Bastiaan Moraal et al. EUROPEAN RADIOLOGY
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) Ludwig Kappos et al. LANCET
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses
- (2008) J Petkau et al. Multiple Sclerosis Journal
- Spinal-Cord MRI in Multiple Sclerosis: Conventional and Nonconventional MR Techniques
- (2008) Joseph CJ. Bot et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessment
- (2008) C. H. Polman et al. NEUROLOGY
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
- (2008) R. Zivadinov et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started